{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:52:30Z","timestamp":1791924750639,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.cpcardiol.2024.102417","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T07:14:13Z","timestamp":1706166853000},"page":"102417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5420-4023","authenticated-orcid":false,"given":"Iva","family":"Minga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kifah","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Wathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safwan","family":"Gaznabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavisha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Macrinici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Hsiung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Singulane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karima","family":"Addetia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitasha","family":"Sarswat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Slivnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Pursnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11 Pt 2","key":"10.1016\/j.cpcardiol.2024.102417_bib0001","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jcmg.2019.06.023","article-title":"Myocardial amyloidosis: the exemplar interstitial disease","volume":"12","author":"Fontana","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102417_bib0002","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/01.JAA.0000697236.11386.3a","article-title":"Understanding and recognizing cardiac amyloidosis","volume":"33","author":"McVeigh","year":"2020","journal-title":"JAAPA"},{"key":"10.1016\/j.cpcardiol.2024.102417_bib0003","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/TCRM.S185677","article-title":"Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): current strategies and guidelines","volume":"16","author":"Benson","year":"2020","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102417_bib0004","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.CIR.63.1.188","article-title":"M-mode and two-dimensional echocardiographic features in cardiac amyloidosis","volume":"63","author":"Siqueira-Filho","year":"1981","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102417_bib0005","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1128\/AAC.00273-06","article-title":"In vivo reversion to the wild-type beta-lactam resistance phenotype mediated by a plasmid carrying ampR and qnrA1 in Enterobacter cloacae","volume":"50","author":"Gonzalez-Lopez","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"47","key":"10.1016\/j.cpcardiol.2024.102417_bib0006","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1093\/eurheartj\/ehw033","article-title":"Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?","volume":"37","author":"Galat","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102417_bib0007","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"10.1016\/j.cpcardiol.2024.102417_bib0008","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1016\/j.jacc.2019.09.056","article-title":"Aortic stenosis and cardiac amyloidosis: JACC review topic of the week","volume":"74","author":"Ternacle","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102417_bib0009","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102417_bib0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1054-8807(03)00057-7","article-title":"Surgical pathology of subaortic septal myectomy not associated with hypertrophic cardiomyopathy: a study of 98 cases (1996-2000)","volume":"12","author":"Allen","year":"2003","journal-title":"Cardiovasc Pathol"},{"issue":"38","key":"10.1016\/j.cpcardiol.2024.102417_bib0011","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Castano","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102417_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.carpath.2009.04.005","article-title":"High prevalence of amyloid in 150 surgically removed heart valves\u2013a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions","volume":"19","author":"Kristen","year":"2010","journal-title":"Cardiovasc Pathol"},{"issue":"4","key":"10.1016\/j.cpcardiol.2024.102417_bib0013","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2559.2012.04265.x","article-title":"Amyloid substance within stenotic aortic valves promotes mineralization","volume":"61","author":"Audet","year":"2012","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102417_bib0014","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1510\/icvts.2008.187179","article-title":"Severe mitral regurgitation due to cardiac amyloidosis\u2013a rare reason for ruptured chordae","volume":"7","author":"Nishi","year":"2008","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"7","key":"10.1016\/j.cpcardiol.2024.102417_bib0015","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.cpcardiol.2024.102417_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2008.11.029","article-title":"Echocardiographic assessment of valve stenosis: EAE\/ASE recommendations for clinical practice","volume":"22","author":"Baumgartner","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102417_bib0017","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ejhf.2606","article-title":"Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis","volume":"24","author":"Chacko","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102417_bib0018","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10554-023-02901-2","article-title":"Valve disease in cardiac amyloidosis: an echocardiographic score","volume":"39","author":"Aimo","year":"2023","journal-title":"Int J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102417_bib0019","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jcmg.2016.03.011","article-title":"Cardiac amyloidosis presenting as severe mitral regurgitation","volume":"9","author":"Ammar","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2024.102417_bib0020","doi-asserted-by":"crossref","unstructured":"Wissanji T, Poulin F, Page M, et al. Advanced Amyloid Cardiomyopathy Unmasked Following Mitral Valve Replacement. CASE (Phila). 2020 Oct;4(5):386-388.","DOI":"10.1016\/j.case.2020.07.005"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102417_bib0021","doi-asserted-by":"crossref","first-page":"483","DOI":"10.4065\/mcp.2009.0706","article-title":"Valvular heart disease: diagnosis and management","volume":"85","author":"Maganti","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102417_bib0022","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.hfc.2023.02.008","article-title":"Arrythmia-Mediated valvular heart disease","volume":"19","author":"Deferm","year":"2023","journal-title":"Heart Fail Clin"},{"issue":"3","key":"10.1016\/j.cpcardiol.2024.102417_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002877","article-title":"Subtype-Specific interactions and prognosis in cardiac amyloidosis","volume":"5","author":"Sperry","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.cpcardiol.2024.102417_bib0024","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ejhf.2650","article-title":"Atrial amyloidosis: mechanisms and clinical manifestations","volume":"24","author":"Vergaro","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"9","key":"10.1016\/j.cpcardiol.2024.102417_bib0025","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial fibrillation in transthyretin cardiac amyloidosis: predictors, prevalence, and efficacy of rhythm control strategies","volume":"6","author":"Donnellan","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"issue":"12","key":"10.1016\/j.cpcardiol.2024.102417_bib0026","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/ejhf.813","article-title":"Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"10.1016\/j.cpcardiol.2024.102417_bib0027","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/ejhf.562","article-title":"Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction","volume":"18","author":"Kajimoto","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"27","key":"10.1016\/j.cpcardiol.2024.102417_bib0028","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1093\/eurheartj\/ehz314","article-title":"Causes and mechanisms of isolated mitral regurgitation in the community: clinical context and outcome","volume":"40","author":"Dziadzko","year":"2019","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.cpcardiol.2024.102417_bib0029","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/heartjnl-2017-311586","article-title":"Isolated tricuspid regurgitation: outcomes and therapeutic interventions","volume":"104","author":"Fender","year":"2018","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.cpcardiol.2024.102417_bib0030","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jcmg.2021.10.015","article-title":"Contemporary etiologies, outcomes, and novel risk score for isolated tricuspid regurgitation","volume":"15","author":"Wang","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.cpcardiol.2024.102417_bib0031","doi-asserted-by":"crossref","first-page":"e13473","DOI":"10.1111\/eci.13473","article-title":"Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis","volume":"51","author":"Volz","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"17","key":"10.1016\/j.cpcardiol.2024.102417_bib0032","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.jcin.2022.06.009","article-title":"Unveiling cardiac amyloidosis, its characteristics, and outcomes among patients with MR undergoing transcatheter edge-to-edge MV repair","volume":"15","author":"Don\u00e0","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.cpcardiol.2024.102417_bib0033","article-title":"Outcomes of transcatheter aortic valve replacement in patients with coexisiting amyloidosis","volume":"2","author":"Elzeneini","year":"2023","journal-title":"JACC: Adv"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624000562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280624000562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:49:09Z","timestamp":1758941349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280624000562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0146280624000562"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102417","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of valvular heart disease in cardiac amyloidosis and impact on survival","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2024.102417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102417"}}